References
Li W, Fu M, Zhao K et al (2020) Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-06444-3 (Epub ahead ofprint)
Scosyrev E, Glimm E (2019) Power analysis for multivariable Cox regression models. Stat Med 38:88–99
Walter SD (2005) The partial area under the summary ROC curve. Stat Med 24:2025–2040
Yang J, Guo X, Zhang H et al (2019) Differential diagnosis of pancreatic serous cystadenoma and mucinous cystadenoma: utility of textural features in combination with morphological characteristics. BMC Cancer 19:1223
Fountzilas E, Kotoula V, Angouridakis N et al (2013) Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer. PLoS ONE 8:e70429
Acknowledgements
I am grateful to Dr. Hui-Zi Li for his professional support for the study.
Funding
None.
Author information
Authors and Affiliations
Contributions
M-SL drafted and revised the letter.
Corresponding author
Ethics declarations
Conflict of interest
The author declares that she has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by the author.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Luo, MS. Letter to the Editor: “Development and validation of a novel metabolic signature for predicting prognosis in patients with laryngeal cancer”. Eur Arch Otorhinolaryngol 278, 3583–3584 (2021). https://doi.org/10.1007/s00405-020-06524-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-020-06524-4